13F-HR filed by WINTON GROUP Ltd
WINTON GROUP Ltd filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-08, with 1,507 holding rows worth $8,456,806,000.
- Accession
- 0001612063-19-000012
- Filer
- CIK 1612063
- Filed
- 2019-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 1,507 entries on the cover page, a total value of $8,456,806,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $8,456,806,000 with VALUE read as thousands by filing date, 13F file number 028-16207. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerWinton Capital Management Ltd
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NAUTILUS INC | 63910B102 | COMMON STOCK | 34,176 | $46,000 | thousands by filing date | |
| SESEN BIO INC | 817763105 | COM | 29,893 | $35,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 10,388 | $34,000 | thousands by filing date | |
| ANTERO RESOURCES CORP COM | 03674X106 | Stock | 10,491 | $32,000 | thousands by filing date | |
| NUVECTRA CORP | 67075N108 | COM | 14,160 | $19,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 22,346 | $19,000 | thousands by filing date | |
| TRANSENTERIX INC | 89366M201 | COM NEW | 23,934 | $15,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001612063-19-000012 | this filing | 2019-11-08 | acceptance time not in the bulk data set |